Albireo, Ferring Ink Deal for Constipation Drug Elobixibat

Albireo AB licensed its constipation drug elobixibat to Ferring Pharmaceuticals SA for an undisclosed up-front fee, plus milestones and tiered double-digit royalties. Terms were not disclosed, but Ferring, of Saint-Prex, Switzerland, said it was one of its biggest product investment deals.